{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:03:25Z","timestamp":1771956205633,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1136\/annrheumdis-2011-201115","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T15:18:24Z","timestamp":1340810304000},"page":"1888-1894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab"],"prefix":"10.1016","volume":"71","author":[{"given":"Vanessa E","family":"Hogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile T J","family":"Holweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F","family":"Choy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K","family":"Kummerfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A","family":"Hackney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y K Onno","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M","family":"vanLaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2011-201115_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","article-title":"Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling.","volume":"233","author":"Manzo","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1136\/annrheumdis-2011-201115_bib2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/art.30292","article-title":"Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium.","volume":"63","author":"Gutierrez-Roelens","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/keq344","article-title":"Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra).","volume":"50","author":"Bansard","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-201115_bib4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.27415","article-title":"Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood.","volume":"62","author":"van Baarsen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011310","article-title":"The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis.","volume":"5","author":"Lindberg","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1136\/annrheumdis-2011-201115_bib6","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.11096","article-title":"Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues.","volume":"48","author":"van der Pouw Kraan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib7","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar2678","article-title":"Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.","volume":"11","author":"Badot","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-201115_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.gene.6363975","article-title":"Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair.","volume":"4","author":"van der Pouw Kraan","year":"2003","journal-title":"Genes Immun"},{"key":"10.1136\/annrheumdis-2011-201115_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib10","series-title":"Bioconductor case studies","author":"Hahne","year":"2008"},{"key":"10.1136\/annrheumdis-2011-201115_bib11","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1002\/art.22967","article-title":"Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.","volume":"56","author":"Teng","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.23148","article-title":"Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.","volume":"58","author":"van Oosterhout","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/art.22400","article-title":"Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.","volume":"56","author":"Vos","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/ard.2007.080960","article-title":"Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response.","volume":"67","author":"Thurlings","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201115_bib15","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1136\/ard.2011.153312","article-title":"Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.","volume":"70","author":"Yeo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201115_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib17","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1002\/art.23059","article-title":"Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis.","volume":"56","author":"Keystone","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/ard.2006.063412","article-title":"Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.","volume":"66","author":"van der Pouw Kraan","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201115_bib19","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/art.27702","article-title":"Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.","volume":"62","author":"Thurlings","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/ard.2010.147199","article-title":"Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.","volume":"70","author":"Vosslamber","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201115_bib21","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/art.10556","article-title":"Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment.","volume":"46","author":"Kraan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201115_bib22","first-page":"229","article-title":"New insight in the mechanism of action of rituximab: the interferon signature towards personalized medicine.","volume":"12","author":"Verweij","year":"2011","journal-title":"Discov Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2011-201115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:03:09Z","timestamp":1737248589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724186438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0003496724186438"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-201115","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-201115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}